Blog
Only 5% of cancer patients participate in clinical trials
There are over 2,000 immunotherapy drugs currently in development. However, a meagre 5% of cancer patients partake in clinical trials, according to a PBS News Hour report. Consequently, America’s second leading cause of death, cancer, continues to claim...
Perspectives on the FDA – Gretchen Bowker will speak during IHIF Life Sciences Lunch
Gretchen Bowker, COO and Head of Quality of Pearl IRB, will share insights during an Indiana Health Industry Forum (IHIF) lunch event on Tuesday, December 19, 2017. The lunch event, "Perspectives on the FDA" is part of IHIF's recurring Life Sciences Lunch...
FDA, EMA recommend more efficient approach to drug development for rare pediatric diseases
The United States Food and Drug Administration (FDA) released a new draft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases, Outsourcing-Pharma.com reports. FDA collaborated with the...
The Power of LinkedIn for Life Science Professionals – Diana Caldwell to deliver presentation at Purdue Foundry
Join Diana Caldwell, President and CEO of Pearl IRB, this Friday, December 1, 2017 at Purdue Foundry as she discusses "The Power of LinkedIn for Life Science Professionals." Foundry Grounds occurs each Friday and involves conversations, presentations &...
Don’t wine about FDA – Gretchen Bowker will lead regulatory approval discussion with VisionTech
Gretchen Bowker, COO and Head of Quality at Pearl IRB, will discuss the regulatory approval process at the VisionTech Partners meeting on Thursday, November 30, 2017. The event, "Don't Wine about FDA - Regulatory 101 with Pearl Pathways," is open to...